UiPath
PATH Β· Systems Software
$14.13
1.4%Qualys
QLYS Β· Systems Software
$216.70
4.1%The short version
- UiPath is the larger business, with $1.6B of revenue in fiscal 2026 against $669M for Qualys, about 2.4 times as much.
- UiPath grew revenue faster (12.7%, against 10.1%).
- Qualys kept more of each dollar of sales as operating profit (33.2% operating margin, against 3.5% operating margin).
- Qualys turned more of its sales into free cash flow (45.5% FCF margin, against 21.9% FCF margin).
- Qualys earned a higher return on the capital invested in it (169.1%, against 13.7%).
- Investors pay more for each dollar of Qualysβs earnings: a P/E of 37.5x against 21.1x for UiPath.
| Latest fiscal year | PATH Β· FY26 | QLYS Β· FY25 |
|---|---|---|
| Size | ||
| Market cap | $7.4B | $7.6B |
| Revenue | $1.6B | $669M |
| Free cash flow | $352M | $304M |
| Net income | $282M | $198M |
| Growth | ||
| Revenue growth | 12.7% | 10.1% |
| 5-year growth | 21.5% | 13.0% |
| Share count change | β2.7% | β2.4% |
| Profitability | ||
| Gross margin | 83.2% | 82.9% |
| Operating margin | 3.5% | 33.2% |
| Net margin | 17.5% | 29.6% |
| FCF margin | 21.9% | 45.5% |
| Return on capital | 13.7% | 169.1% |
| Return on equity | 14.4% | 38.2% |
| Balance sheet | ||
| Net debt | β$1.5B | β$446M |
| Net debt / EBITDA | β20.0x | β1.9x |
| Dividends and buybacks | $329M | $183M |
| Valuation & quality | ||
| P/E | 21.1x | 37.5x |
| Piotroski F-score | 7 | 6 |
FY17
PATH β
QLYS $231M
FY18
PATH β
QLYS $279M
FY19
PATH β
QLYS $322M
FY20
PATH $336M
QLYS $363M
FY21
PATH $608M
QLYS $411M
FY22
PATH $892M
QLYS $490M
FY23
PATH $1.1B
QLYS $555M
FY24
PATH $1.3B
QLYS $608M
FY25
PATH $1.4B
QLYS $669M
FY26
PATH $1.6B
QLYS β
PATH
QLYS
FY17
PATH β
QLYS 16.1%
FY18
PATH β
QLYS 18.1%
FY19
PATH β
QLYS 22.5%
FY20
PATH β153.9%
QLYS 26.6%
FY21
PATH β18.2%
QLYS 21.3%
FY22
PATH β56.1%
QLYS 26.7%
FY23
PATH β32.9%
QLYS 29.4%
FY24
PATH β12.6%
QLYS 30.8%
FY25
PATH β11.4%
QLYS 33.2%
FY26
PATH 3.5%
QLYS β
PATH
QLYS
FY17
PATH β
QLYS $69.8M
FY18
PATH β
QLYS $103M
FY19
PATH β
QLYS $133M
FY20
PATH β$375M
QLYS $150M
FY21
PATH $27.2M
QLYS $176M
FY22
PATH β$63.8M
QLYS $183M
FY23
PATH β$33.8M
QLYS $236M
FY24
PATH $292M
QLYS $232M
FY25
PATH $306M
QLYS $304M
FY26
PATH $352M
QLYS β
PATH
QLYS
FY17
PATH β
QLYS β
FY18
PATH β
QLYS 81.3%
FY19
PATH β
QLYS 79.8%
FY20
PATH β
QLYS β
FY21
PATH β
QLYS β
FY22
PATH β
QLYS β
FY23
PATH β
QLYS β
FY24
PATH β
QLYS β
FY25
PATH β
QLYS 169.1%
FY26
PATH 13.7%
QLYS β
PATH
QLYS
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.